Overcoming tumour resistance to anti-cancer agent TRAIL
Tuesday, March 23, 2010 - 09:14
in Biology & Nature
The TRAIL ligand is a promising anticancer agent that preferentially kills tumour cells without apparent damage to healthy cells. Many cancers exhibit resistance to TRAIL, however, thus limiting its therapeutic potential. According to a study in the March 22 issue of the Journal of Cell Biology (www.jcb.org), small molecules known to block Mcl-1 (induced myeloid leukaemia cell differentiation protein) might represent a suitable means to overcome TRAIL resistance...